Saturday, May 21, 2022
wellness India Expo
Home Tags SARS-CoV-2

Tag: SARS-CoV-2

Scientists develop new technology platform to detect SARS-CoV-2

A highlight of the study is that it presents an entirely new strategy to target a unique, unconventional nucleic acid structure specific to the SARS-CoV-2 sequence using small molecules

Thermo Fisher Scientific to continue focusing on SARS-CoV2 diagnostic solutions: Amit...

Our endeavor has always been to develop innovative, adaptive, and resilient testing solutions that leverage our capabilities to address the public health crisis, says Amit Chopra, Managing Director, India and South Asia, Thermo Fisher Scientific

Thermo Fisher Scientific claims its TaqPath COVID-19 tests can detect Omicron...

The TaqPath COVID-19 assays detect SARS-CoV-2 infections by identifying the presence of three gene targets from the orf1a/b, S, and N regions of the virus

Israeli researchers develop a therapeutic approach that could put a super...

Rather than targeting the viral protein responsible for the virus entering the cell, the team of researchers addressed the protein on our cells’ membrane that enables this entry.........................

IIT Delhi launches economical Rapid Antigen Test Kit for COVID-19

This kit can be used for in vitro qualitative detection of SARS-CoV-2 antigen, suitable for general population screening and diagnosis of COVID-19........................

Healthy young adults with COVID-19 may have long-term impact on blood...

Healthy adults with mild COVID-19 symptoms may increase their risk of cardiovascular complications which may continue for some time after COVID-19 infection.....................

Decoding CSIR-IICT’s role in development of Bharat Biotech’s COVAXIN

CSIR-Indian Institute of Chemical Technology (IICT) based in Hyderabad, was approached by BBIL to develop the synthetic route for the agonist molecule with indigenous chemicals at an affordable price and with the highest purity..................

We are moving towards herd immunity: AIIMS Professor

No need to be panic about the new strain of COVID, it’s not as virulent as the reports are coming in.....................

Cipla launches ‘CIPtest’ rapid antigen detection test for COVID-19 diagnosis

Validated and approved by ICMR, the test is found to have specificity and sensitivity of 98.09% and up to 75% respectively. This is Cipla’s second launch in the diagnostics space after Elifast: SARS CoV-2 IgG ELISA Test Kit......................

Time is a critical factor in plasma collection post COVID-19 recovery:...

In a new study, researchers report that antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the virus and symptoms have subsided............................